Considerations to accelerating and maximize the preclinical studies to a safe and effective COVID-19 vaccine
<p>The emergence of novel coronavirus-2019 (COVID-19) by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) virus and its rapid spread across the world have triggered a global health emergency without preceding. From the first report of COVID-19 at Wuhan city of China in December 201...
Bewaard in:
Hoofdauteur: | |
---|---|
Formaat: | Boek |
Gepubliceerd in: |
Journal of Vaccines and Immunology - Peertechz Publications,
2021-01-25.
|
Onderwerpen: | |
Online toegang: | Connect to this object online. |
Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|
Internet
Connect to this object online.3rd Floor Main Library
Plaatsingsnummer: |
A1234.567 |
---|---|
Kopie 1 | Beschikbaar |